MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 138 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $542,336 | +10.8% | 6,400 | +27.4% | 0.00% | +33.3% |
| Q2 2021 | $489,290 | -16.3% | 5,023 | +0.5% | 0.00% | -40.0% |
| Q1 2021 | $584,850 | +5.2% | 5,000 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $555,850 | -6.4% | 5,000 | 0.0% | 0.00% | -42.9% |
| Q3 2020 | $594,000 | -47.5% | 5,000 | -50.0% | 0.01% | -50.0% |
| Q2 2020 | $1,132,000 | +160.8% | 10,000 | +53.8% | 0.01% | +180.0% |
| Q1 2020 | $434,000 | -85.6% | 6,500 | -80.4% | 0.01% | -78.3% |
| Q4 2019 | $3,018,000 | -53.3% | 33,128 | -55.8% | 0.02% | -54.0% |
| Q3 2019 | $6,456,000 | -46.7% | 74,872 | -35.2% | 0.05% | -43.8% |
| Q2 2019 | $12,118,000 | -47.5% | 115,621 | -37.3% | 0.09% | -53.2% |
| Q1 2019 | $23,102,000 | +0.3% | 184,436 | -9.8% | 0.19% | +1.1% |
| Q4 2018 | $23,038,000 | +19.7% | 204,379 | +127.3% | 0.19% | +49.2% |
| Q3 2018 | $19,252,000 | – | 89,910 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |